07:30-08:15
Satellite Symposium 3:
Novartis Korea Ltd.
Room 1 (Vista 1+2)
07:30-08:15
08:30-09:45
Symposium 5:
Biomarker-Driven Adaptive Surgery in the Era of Neoadjuvant Therapy
Room 1 (Vista 1+2)
08:30-09:45
Panel Discussion 4:
Current Landscapes and Future Prospectives of HER2 low/ultralow Breast Cancer
Room 2 (Grand 1)
08:30-09:45
Symposium 6:
AI Across Breast Imaging
Room 3 (Walker 1)
08:30-09:45
Nursing Session 1 (Kor.):
From Surgery to Systemic Therapy: Managing Physical Complication in Breast Cancer Care
Room 4 (Walker 2)
08:30-09:45
GBCC-JBCS-TBCS Joint Session:
Current Evidence of Ovarian Function Suppression and Real-World Practice in Asia
Room 5 (Art Hall)
08:30-09:45
09:45-10:00
Poster Discussion 3
Exhibition (Grand)
09:45-10:00
10:00-11:15
General Session 2
Room 1 (Vista 1+2)
10:00-11:15
Multidisciplinary Session:
Integrating AI into Cancer Treatment
Room 2 (Grand 1)
10:00-11:15
Education Session 2:
Modern Axillary Care in Breast Cancer: Integrating Surgical, Imaging and Pathologic Insights
Room 3 (Walker 1)
10:00-11:15
Nursing Session 2 (Kor.):
Unmet Needs and Holistic Care in Patient with Metastatic or Recurrent Breast Cancer
Room 4 (Walker 2)
10:00-11:15
Mini Oral Presentation 3
Room 5 (Art Hall)
10:00-11:15
11:30-12:15
Plenary Lecture 3:
Next Generation ADCs
Room 1 (Vista 1+2)
11:30-12:15
12:30-13:15
Satellite Symposium 4:
Daiichi-Sankyo Korea
Room 1 (Vista 1+2)
12:30-13:15
Satellite Symposium 5:
Roche Korea Co., Ltd.
Room 2 (Grand 1)
12:30-13:15
13:30-14:15
Plenary Lecture 4:
What Does it Take to Make Precision Oncology Precise?
Room 1 (Vista 1+2)
13:30-14:15
14:15-14:30
Poster Discussion 4
Exhibition (Grand)
14:15-14:30
14:30-15:20
Junior Doctors Forum
Room 4 (Walker 2)
14:30-15:20
14:30-15:45
Symposium 7:
Evolving Landscape of HR+/HER2- Metastatic Breast Cancer Treatment
Room 1 (Vista 1+2)
14:30-15:45
Panel Discussion 5:
Modern Axillary Management in Breast Cancer with Regional Nodal Involvement
Room 2 (Grand 1)
14:30-15:45
Education Session 3:
Breast Cancer Related Lymphedema: Etiologic Factors and Risk Stratification
Room 3 (Walker 1)
14:30-15:45
Mini Oral Presentation 4
Room 5 (Art Hall)
14:30-15:45
15:35-17:15
Junior Doctors Debate
Room 4 (Walker 2)
15:35-17:15
16:00-17:15
Symposium 8:
De-escalation of Breast Cancer Surgery: What We Know vs. What We Actually Do
Room 1 (Vista 1+2)
16:00-17:15
Symposium 9:
Shaping the Future of Breast Cancer Treatment with Antibody Drug Conjugates
Room 2 (Grand 1)
16:00-17:15
Education Session 4:
Locoregional Management for Lymph Node Positive Breast Cancer
Room 3 (Walker 1)
16:00-17:15
Education Session 5:
Enhancing and Optimizing Survivorship Throughout Cancer Treatment
Room 5 (Art Hall)
16:00-17:15